Media Home | Contact Us

Media Relations Links • About Us • Media Contact • Frequently Asked Questions • Media Site Map CDC News • Press Release Library • Transcripts • MMWR Summaries • B-Roll Footage • Upcoming Events Related Links • Centers at CDC • Data and Statistics • Health Topics A-Z • Image Library • Publications, Software and Other Products • Global Health Odyssey Find your state or local health department HHS News National Health Observances Div. of Media Relations 1600 Clifton Road MS D-14 Atlanta, GA 30333 (404) 639-3286 Fax (404) 639-7394

October 22, 2001/6:00 PM, ET Contact: CDC Press Office (404) 639-3286 Press Release CDC Update: CDC summary of confirmed cases of anthrax and background information CDC-confirmed cases of anthrax Based on a rigorous case definition, CDC is reporting 9 confirmed cases of anthrax: 2 in Florida, 3 in New York, 2 in New Jersey, and 2 in D.C. (in collaboration with MD and VA).  One additional unconfirmed case under investigation at the New York Post. CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests.   Background ·       Inhalation anthrax is the most serious and rare form of human anthrax. It occurs when a person breathes anthrax spores that are in the air. Initial symptoms may resemble the common cold (including fever, muscle aches, and fatigue). After several days, symptoms may progress to severe breathing problems and shock.  If left untreated, inhalation anthrax can be fatal. ·       Cutaneous (skin) anthrax is different from inhalation anthrax. A cutaneous infection due to anthrax can occur if the spores are in contact with an area of skin that is not intact, such as a cut or sore. Cutaneous anthrax is marked by a boil-like lesion that eventually forms an ulcer with a black center. The cutaneous forms respond well to antibiotics if treatment is started soon after symptoms appear. ·       For people with suspected anthrax disease, laboratory testing is essential to diagnosis. Tests may include: o      Cultures of blood and spinal fluid (should be done before antibiotic treatment has been initiated) o      Cultures of tissue of fluids from affected areas. o      Microscopic examination of tissue. o      PCR (polymerase chain reaction) test that amplifies trace amounts of DNA to document that the anthrax bacteria is present. ·       Antibiotics are an effective treatment if the disease is diagnosed early on; but anthrax can be fatal if left untreated. ·       Anthrax is NOT contagious from one person to another. Family members and contacts of persons who work in or visited the building are not at risk and antibiotic therapy is not recommended for them. Other members of the community are not at risk. Public health officials, together with the FBI, are continuing the investigation. ·       The Centers for Disease Control and Prevention continues to work with state and local health departments, law enforcement officials, and other federal agencies to investigate incidents of possible anthrax exposures around the United States.  In Atlanta, CDC officials continue to work out of a 24-hour Operations Center.  The Operations Center staff is also responding to hundreds of calls each day from the public.  CDC has dispatched more than three dozen employees to either Florida, New York City, or Washington, D.C.  More than 50 CDC laboratories have processed hundreds of specimens. For the latest update on CDC activities and on-going anthrax investigations visit www.bt.cdc.gov/ or www.cdc.gov/media/.

Media Home | Contact Us CDC Home | Search | Health Topics A-Z This page last reviewed October 22, 2001 URL: Centers for Disease Control and Prevention